A CAR T cell therapy for advanced ovarian cancer developed

by City of Hope National Medical CenterMembrane-bound IL-12 engineered TAG72-CAR T cells induce higher IFNγ, T-cell expansion, and anti-tumor activity in vitro.a–cTumor cell killing o

Updated on: February 18,2024 10

A CAR T cell therapy for advanced ovarian cancer developed

by City of Hope National Medical CenterMembrane-bound IL-12 engineered TAG72-CAR T cells induce higher IFNγ, T-cell expansion, and anti-tumor activity in vitro.a–cTumor cell killing o

Updated on:February 18,2024 10

New, rare type of small cell lung cancer identified

by Ian Demsky,Memorial Sloan Kettering Cancer CenterOn the left, four pathology images from a patient with atypical small cell lung cancer show hallmarks of carcinoid cancer in the lungs (thorax

Updated on: September 30,2024 0

New, rare type of small cell lung cancer identified

by Ian Demsky,Memorial Sloan Kettering Cancer CenterOn the left, four pathology images from a patient with atypical small cell lung cancer show hallmarks of carcinoid cancer in the lungs (thorax

Updated on:September 30,2024 0

Numbers count in the genetics of moles and melanomas

by University of QueenslandReticular naevi pattern (left) Gene variations: MTAP, PLA2G6, MITF. Globular naevi pattern (right) Gene variations: IRF4. Credit: University of QueenslandUniversity of

Updated on: April 20,2024 12

Numbers count in the genetics of moles and melanomas

by University of QueenslandReticular naevi pattern (left) Gene variations: MTAP, PLA2G6, MITF. Globular naevi pattern (right) Gene variations: IRF4. Credit: University of QueenslandUniversity of

Updated on:April 20,2024 12

Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainDespite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or

Updated on: May 07,2024 11

Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainDespite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or

Updated on:May 07,2024 11

Researchers discover common markers of tumor hypoxia across 19 cancer types

by Ontario Institute for Cancer ResearchUnlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despit

Updated on: June 22,2024 6

Researchers discover common markers of tumor hypoxia across 19 cancer types

by Ontario Institute for Cancer ResearchUnlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despit

Updated on:June 22,2024 6

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi

Updated on: July 17,2024 0

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi

Updated on:July 17,2024 0

Long-term study finds faster breast cancer radiation treatment as effective as long course

by McMaster UniversityTimothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Re

Updated on: April 18,2024 20

Long-term study finds faster breast cancer radiation treatment as effective as long course

by McMaster UniversityTimothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Re

Updated on:April 18,2024 20

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi

Updated on: April 14,2024 20

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi

Updated on:April 14,2024 20

Social vulnerability tied to worse pediatric head and neck cancer outcomes

by Lori SolomonAmong pediatric patients with head and neck cancers (HNCs), increasing social vulnerability is associated with significant decreases in receipt of care and survival time, according to a

Updated on: January 04,2024 9

Social vulnerability tied to worse pediatric head and neck cancer outcomes

by Lori SolomonAmong pediatric patients with head and neck cancers (HNCs), increasing social vulnerability is associated with significant decreases in receipt of care and survival time, according to a

Updated on:January 04,2024 9

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /

Updated on: January 02,2024 8

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /

Updated on:January 02,2024 8

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Updated on: July 05,2024 0

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Updated on:July 05,2024 0

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Updated on: January 16,2024 12

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Updated on:January 16,2024 12